Author Correction: An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients

被引：0
|
作者：
Rajan Ravichandran
Surapaneni Krishna Mohan
Suresh Kumar Sukumaran
Devakumar Kamaraj
Sumetha Suga Daivasuga
Samson Oliver Abraham Samuel Ravi
Sivakumar Vijayaraghavalu
Ramarathnam Krishna Kumar
机构：
[1] MIOT International,Department of Nephrology
[2] Indian Institute of Technology Madras (IITM),Adjunct Faculty
[3] Panimalar Medical College Hospital and Research Institute,Departments of Biochemistry, Molecular Virology and Research
[4] Panimalar Medical College Hospital and Research Institute,Department of General Medicine
[5] Panimalar Medical College Hospital and Research Institute,Departments of Pharmacology and Research
[6] Panimalar Medical College Hospital and Research Institute,Departments of Microbiology and Molecular Virology
[7] Molbio Diagnostics Private Limited,School of Life Sciences
[8] Manipur University,Department of Engineering Design
[9] IITM,undefined
来源：
Scientific Reports | / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
    Ravichandran, Rajan
    Mohan, Surapaneni Krishna
    Sukumaran, Suresh Kumar
    Kamaraj, Devakumar
    Daivasuga, Sumetha Suga
    Ravi, Samson Oliver Abraham Samuel
    Vijayaraghavalu, Sivakumar
    Kumar, Ramarathnam Krishna
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [2] Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
    Philippe Bégin
    Jeannie Callum
    Erin Jamula
    Richard Cook
    Nancy M. Heddle
    Alan Tinmouth
    Michelle P. Zeller
    Guillaume Beaudoin-Bussières
    Luiz Amorim
    Renée Bazin
    Kent Cadogan Loftsgard
    Richard Carl
    Michaël Chassé
    Melissa M. Cushing
    Nick Daneman
    Dana V. Devine
    Jeannot Dumaresq
    Dean A. Fergusson
    Caroline Gabe
    Marshall J. Glesby
    Na Li
    Yang Liu
    Allison McGeer
    Nancy Robitaille
    Bruce S. Sachais
    Damon C. Scales
    Lisa Schwartz
    Nadine Shehata
    Alexis F. Turgeon
    Heidi Wood
    Ryan Zarychanski
    Andrés Finzi
    Donald M. Arnold
    Nature Medicine, 2022, 28 : 212 - 212
  • [3] Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease
    Manaf AlQahtani
    Nitya Kumar
    Dhuha Aljawder
    Abdulkarim Abdulrahman
    Mohammed Wael Mohamed
    Fatema Alnashaba
    Mohammed Abu Fayyad
    Faisal Alshaikh
    Fatima Alsahaf
    Sawsan Saeed
    Amal Almahroos
    Zainab Abdulrahim
    Sameer Otoom
    Stephen L. Atkin
    Scientific Reports, 12
  • [4] A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19
    Fowotade, Adeola
    Bamidele, Folasade
    Egbetola, Boluwatife
    Fagbamigbe, Adeniyi F.
    Adeagbo, Babatunde A.
    Adefuye, Bolanle O.
    Olagunoye, Ajibola
    Ojo, Temitope O.
    Adebiyi, Akindele O.
    Olagunju, Omobolanle I.
    Ladipo, Olabode T.
    Akinloye, Abdulafeez
    Onayade, Adedeji
    Bolaji, Oluseye O.
    Rannard, Steve
    Happi, Christian
    Owen, Andrew
    Olagunju, Adeniyi
    FRONTIERS IN MEDICINE, 2022, 9
  • [5] Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
    Sekine, Leo
    Arns, Beatriz
    Fabro, Bruna R.
    Cipolatt, Murillo M.
    Machado, Rafael R. G.
    Durigon, Edison L.
    Parolo, Edino
    Pellegrini, Jose Augusto S.
    Viana, Marina V.
    Schwarz, Patricia
    Lisboa, Thiago C.
    Dora, Jose Miguel S.
    Portich, Julia P.
    Paz, Alessandra A.
    Silla, Lucia
    Balsan, Almeri M.
    Schirmer, Felipe Da-Silva
    Franz, Juliana P. M.
    Da-Silveira, Luciana M.
    Breunig, Raquel C.
    Petersen, Viviana
    Sosnoski, Monalisa
    Mesquita, Nanci F.
    Volpato, Fabiana Caroline Z.
    Sganzerla, Daniel
    Falavigna, Maicon
    Rosa, Regis G.
    Zavascki, Alexandre P.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (02)
  • [6] Efficacy of Favipiravir in the Treatment of Moderate COVID-19 Patients: A Randomized, Open-label, Controlled Clinical Trial
    Tehrani, Shabnam
    Yadegarynia, Davood
    Bagherzade, Afshin
    Gachkar, Latif
    Keyvanfar, Amirreza
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2022, 11
  • [7] Psychological effect of mild to moderate COVID-19 on hospitalised patients
    Aziz, Sadaf
    Chaudhary, Suprakash
    Saldanha, Daniel
    INDIAN JOURNAL OF PSYCHIATRY, 2022, 64
  • [8] Psychological effect of mild to moderate COVID-19 on hospitalised patients
    Aziz, Sadaf
    Chaudhary, Suprakash
    Saldanha, Daniel
    INDIAN JOURNAL OF PSYCHIATRY, 2022, 64 (SUPPL 3) : S599 - S600
  • [9] Lavender (Lavandula angustifolia) syrup as an adjunct to standard care in patients with mild to moderate COVID-19: An open-label, randomized, controlled clinical trial
    Qaraaty, Marzieh
    Bahrami, Mohsen
    Azimi, Sadegh-Ali
    Hashem-Dabaghian, Fataneh
    Saberi, Safoora
    Zaidi, Syed Mohd Abbas
    Sahebkar, Amirhossein
    Enayati, Ayesheh
    AVICENNA JOURNAL OF PHYTOMEDICINE, 2023, 13 (04) : 400 - 411
  • [10] Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
    Dongsheng Wang
    Binqing Fu
    Zhen Peng
    Dongliang Yang
    Mingfeng Han
    Min Li
    Yun Yang
    Tianjun Yang
    Liangye Sun
    Wei Li
    Wei Shi
    Xin Yao
    Yan Ma
    Fei Xu
    Xiaojing Wang
    Jun Chen
    Daqing Xia
    Yubei Sun
    Lin Dong
    Jumei Wang
    Xiaoyu Zhu
    Min Zhang
    Yonggang Zhou
    Aijun Pan
    Xiaowen Hu
    Xiaodong Mei
    Haiming Wei
    Xiaoling Xu
    Frontiers of Medicine, 2021, 15 : 486 - 494
12345